BLOG: You are never too busy to care for the ocular surface

Some eye care specialists may believe they do not have time have time to deal with ocular surface disease — that tackling dry eye disease is too time-consuming, complicated and confusing, potentially making them inefficient with patients.
BLOG: New IOL designs seek to overcome postop visual disturbances

Undesirable subjective optical patterns known as dysphotopsias are one of the most common complaints following cataract surgery.
BLOG: How to get started with presbyopia-correcting drops

With a new pharmaceutical treatment option, my conversations with presbyopic patients have gotten a lot more exciting.
BLOG: Presbyopia correcting drops poised to expand the toolkit

A pharmaceutical approach to presbyopia has clear advantages, will likely be used in combination with other approaches and may serve to drive surgical procedures.
BLOG: Help your surgeon, patients by optimizing the corneal surface
Visual outcomes after cataract surgery depend on accurate planning.
BLOG: How to tell patients they have a cataract
Most patients know about cataracts, but they might not fully understand what they are.
BLOG: Dry eye pipeline remains robust

Despite stalls in development due to COVID-19, eye care providers can look forward to new treatments for ocular surface disease. As our understanding of the disease and its underlying mechanisms broadens, so does the industry's response.
BLOG: COVID-19 induces practices to explore new efficiencies
Our practice was shuttered at the beginning of the COVID-19 pandemic to all but emergent patients.
BLOG: LASIK in 2020 – ‘State of the union’
This third installment of the current state of LASIK looks at more data and thoughts about the future.
BLOG: LASIK in 2020 – Safer, more precise, better than ever
This overview takes a look at the “state of the union” as it relates to LASIK as we know it in this year of vision, 2020. Here is part two, focusing on FDA approval, current iterations and data.